CROSS COUNTRY HEALTHCARE INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)

tr>
 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

© Edgar Online, source Glimpses

Share

© Acquiremedia - 2020

Latest news about Cross Country Healthcare, Inc.

Cross Country Healthcare, Inc. Releases Latest Research Findings in the Fourth Annual Installment of the Future of Nursing Survey	04-25	CI
Barrington Cuts Price Target on Cross Country Healthcare to $24 From $26, Keeps Outperform Rating	02-27	MT
UBS Adjusts Cross Country Healthcare Price Target to $19 From $22, Maintains Neutral Rating	02-23	MT
Truist Adjusts Cross Country Healthcare's Price Target to $16 From $22, Keeps Hold Rating	02-22	MT
Transcript : Cross Country Healthcare, Inc., Q4 2023 Earnings Call, Feb 21, 2024	02-21
Earnings Flash (CCRN) CROSS COUNTRY HEALTHCARE Posts Q4 EPS $0.29, vs. Street Est of $0.27	02-21	MT
Earnings Flash (CCRN) CROSS COUNTRY HEALTHCARE Posts Q4 Revenue $414M, vs. Street Est of $404.5M	02-21	MT
(CCRN) CROSS COUNTRY HEALTHCARE Expects Q1 EPS Range $0.15 - $0.25	02-21	MT
Cross Country Healthcare, Inc. Announces Daniel J. White Departs as Chief Commercial Officer, Effective March 31, 2024	02-21	CI
Tranche Update on Cross Country Healthcare, Inc.'s Equity Buyback Plan announced on August 16, 2022.	02-21	CI
Cross Country Healthcare, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-21	CI
Cross Country Healthcare, Inc. Provides Earnings Guidance for the First Quarter of 2024	02-21	CI
Cross Country Healthcare, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-21	CI
JMP Securities Initiates Cross Country Healthcare With Market Perform Rating	12-06	MT
UBS Initiates Coverage on Cross Country Healthcare With Neutral Rating, $22 Price Target	11-30	MT
Barrington Cuts Price Target on Cross Country Healthcare to $26 From $29, Keeps Outperform Rating	11-29	MT
Cross Country Healthcare Insider Sold Shares Worth $119,460, According to a Recent SEC Filing	11-06	MT
North American Morning Briefing : Stocks Look to -2-	11-06	DJ
Jefferies Downgrades Cross Country Healthcare to Hold From Buy, Adjusts Price Target to $21 From $32	11-03	MT
Transcript : Cross Country Healthcare, Inc., Q3 2023 Earnings Call, Nov 01, 2023	11-01
Tranche Update on Cross Country Healthcare, Inc.'s Equity Buyback Plan announced on August 16, 2022.	11-01	CI
Cross Country Healthcare, Inc. Provides Earnings Guidance for the Fourth Quarter of 2023	11-01	CI
Cross Country Healthcare, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-01	CI
Cross Country Healthcare, Inc. Amends its ABL Credit Agreement	23-10-02	CI
Barrington Cuts Price Target on Cross Country Healthcare to $29 From $35 Amid Reduction in Estimates, Keeps at Outperform	23-08-14	MT